Effects of Carnosine Supplementation on Cognitive Outcomes in Prediabetes and Well-Controlled Type 2 Diabetes: A Randomised Placebo-Controlled Clinical Trial
Hariharan R, Mousa A, Menon K, Feehan J, et al.
Published in Pharmaceuticals
Abstract
Randomised placebo-controlled trial of carnosine and cognitive outcomes in prediabetes and type 2 diabetes.
Key Findings
Fourteen weeks of carnosine supplementation did not improve any cognitive domain compared with placebo in adults with prediabetes or well-controlled type 2 diabetes.
Conclusions
This null trial does not support carnosine for cognitive benefit in dysglycemia.
Limitations
Modest sample, relatively healthy cognition at baseline, 14-week duration.
Supplements Studied
Fourteen weeks of carnosine supplementation did not improve any cognitive domain compared with placebo in adults with prediabetes or well-controlled type 2 diabetes.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.